Reid Laurence insider trades
Reid Laurence has filed 9 Form 4s with the SEC that we hold, for DBTX (See Remarks, Director), Metagenomi Therapeutics, Inc. (MGX) (Director) and KALV (Director). Across all of them we count 3 purchases worth $99.8K and 0 sales worth $0 reported on Form 4. In the last 12 months: 2 purchases ($23.4K) and 0 sales ($0). The largest single trade was a purchase of 10,000 shares of DBTX worth $76.4K, dated 2021-09-15. The first filing on our record is dated 2021-09-17 and the latest 2026-09-11.
DBTX
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-09-15 | P, purchase reported on Form 4 | 10,000 | $76.4K | 2021-09-17 |
Metagenomi Therapeutics, Inc. (MGX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-09-09 | P, purchase reported on Form 4 | 19,883 | $23.3K | 2026-09-11 |
| 2026-09-09 | P, purchase reported on Form 4 | 117 | $138 | 2026-09-11 |
KALV
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1492749) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms